StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie income tax expense ($M) ($M)

Form 10-Q / 10-K

QuarterlyAnnual
Latest, Q2 2026
662
Period ended Jun 30, 2026
Change on a year earlier
+8.0%
613 in Q2 2025
History
58 quarters
Since Q1 2012
Sources
54
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIncome tax expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026662+8.0%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 2026342-8.1%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 2025853-138.0%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 2025526+1.2%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025613-20.7%Form 10-Q (filed 2025-08-04) ↗
Q1 2025Mar 31, 2025372-2.9%Form 10-Q (filed 2025-05-09) ↗
Q4 2024Dec 31, 2024-2,246-678.9%Form 10-K (filed 2025-02-14) ↗
Q3 2024Sep 30, 2024520+202.3%Form 10-Q (filed 2024-11-04) ↗
Q2 2024Jun 30, 2024773+32.6%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 2024383+63.7%Form 10-Q (filed 2024-05-03) ↗
Q4 2023Dec 31, 2023388-21.3%Form 10-K (filed 2024-02-20) ↗
Q3 2023Sep 30, 2023172-61.6%Form 10-Q (filed 2023-11-06) ↗
Q2 2023Jun 30, 2023583+128.6%Form 10-Q (filed 2023-08-07) ↗
Q1 2023Mar 31, 2023234-46.3%Form 10-Q (filed 2023-05-05) ↗
Q4 2022Dec 31, 2022493+118.1%Form 10-K (filed 2023-02-17) ↗
Q3 2022Sep 30, 2022448-11.8%Form 10-Q (filed 2022-11-04) ↗

Cite this data

StockData. (2026). AbbVie Income tax expense ($M) ($M), quarterly Q1 2012–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_tax

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.